MDR 3.45% 30.0¢ medadvisor limited

Social Media, page-70

  1. 3,108 Posts.
    lightbulb Created with Sketch. 84
    Management used to be more regular with announcements.

    New PEP customers, subscriber number milestones, additional platform integration were all celebrated. It seems the only time detail like this is published is in quarterlies. PEP customers have grown but I can't recall the recent ones were publicised.

    The share price over the last 6 months is evident of this announcement style. Company making deals provide spikes in share price, the gaps between sees the price slide.

    I've held other stocks where multiple insignificant progress updates, with much fanfare, were the norm. This led to announcements being sold into, with each one dropping the price further.

    I'm hoping for another significant announcement in the coming month(s) which should see another re-rate and perhaps new highs. All previous broker reports suggest CY2018 for a tangible international update. Whilst it would be great to see this before FY18, I think it will be later in the year, reason being, as stated above - Management are choosing the under promise, over deliver style only publishing significant achievements.

    I think we saw yesterday support arrive when the share price dipped below 4.5c. Buying at these levels retail is getting a better deal than EBOS ($1M at 5c / $9.5M at 5.75c).
    Last edited by futurenow: 15/03/18
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.010(3.45%)
Mkt cap ! $215.0M
Open High Low Value Volume
29.0¢ 30.0¢ 27.5¢ $254.8K 889.6K

Buyers (Bids)

No. Vol. Price($)
2 39326 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 2917 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.